Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 19,191 shares at $3.00 ($59K) on 2025-04-30, disclosed to the SEC on 2025-04-30.
Scheduled sale ($59k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.17 | 981 | $3K | 5.3% |
| 2 | $3.17 | 1,709 | $5K | 9.2% |
| 3 | $3.23 | 3,558 | $11K | 19.5% |
| 4 | $3.00 | 12,943 | $39K | 66.0% |
| Total | $3.07 avg | 19,191 | $59K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $3.2M | — | Filing → |